WASHINGTON — Seeking to calm the concerns of his Evangelical supporters, President Donald Trump clarified that the only human fetal cells that were used for the experimental antibody “cocktail” produced by Regeneron Pharmaceuticals came from embryos that were harvested below the southern border of the United States.
The antibody therapy, known as REGN-COV2, that was administered to President Trump as part of his COVID-19 treatment at the Walter Reed National Military Medical Center was created through research that involved human embryonic stem cells. But physicians at the hospital were instructed to specifically use a batch of REGN-COV2 that was created using Mexican embryonic stem cells in the cocktail used to treat President Trump.
“I told them, I said, I only want the Mexicans. Only the Mexican babies,” President Trump said to reporters. He added, “but not too spicy, not too spicy. A mild Mexican baby is the idea.”
President Trump, who has referred to Mexicans as criminals, rapists, and good people in the past, made the comments in response to criticism that his treatment involved stem cells taken from aborted fetuses.
A statement from Regeneron Pharmaceuticals issued in April 2020 says that the company utilizes a “wide variety of research tools and technologies to help discover and develop new therapeutics. Stem cells are one such tool.” While the statement doesn’t specifically refer to the antibody therapy used in the cocktail that was administered to President Trump, it does suggest that human fetal cells were indeed used in the drug’s creation.
A physician familiar with the president’s treatment at Walter Reed admitted that the process of separating the Mexican embryonic stem cells from non-Mexican embryonic stem cells wasn’t easy or an exact science.
“We had trouble getting all of the Guatemalan fetal cells out of the mix,” the source admitted. “In the end, we had to leave some of the Honduran cells in there, but we don’t think he knew the difference.”